GAINESVILLE — Rep. Doug Collins (R-Ga.) today announced Amneal Pharmaceuticals, Inc., one of the largest U.S.-based generics manufacturers, has donated 200,000 doses of hydroxychloroquine sulfate to Georgia’s Department of Public Health for potential use in treating hospitalized COVID—19 patients.
“On behalf of the people of Georgia, I want to thank Amneal Pharmaceuticals for this incredible donation,” said Collins. “This medication could be pivotal in Georgia’s fight against COVID—19 and could potentially save thousands of lives across our state. Acts of generosity like this remind us of the remarkable ways in which our country has rallied together to support one another in the face of this crisis, and I’m humbled to have worked with Amneal and Georgia’s Department of Public Health to help secure this donation on behalf of our state. We will beat this virus, and our nation will emerge stronger than ever before.”
“All of us at Amneal Pharmaceuticals are committed to assisting our communities in the global fight against COVID-19,” said Chirag Patel, Co-CEO of Amneal Pharmaceuticals.
Hydroxychloroquine sulfate is currently used to treat malaria, rheumatoid arthritis, lupus, and other autoimmune diseases. It has recently been identified as a possible treatment for COVID—19 and the federal government has requested its immediate availability.
Georgia is one of the first states to have received a donation of hydroxychloroquine sulfate from Amneal Pharmaceuticals, Inc. Amneal is also donating and providing products directly to hospitals across the nation.